Navigation Links
HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) Assay Kits and Contract Research Services
Date:12/3/2008

COLORADO SPRINGS, Colo. and REYKJAVIK, Iceland, Dec. 3 /PRNewswire/ -- HemoGenix(R) and ORF Genetics announce the collaboration and implementation of biorisk-free, green-source growth factors and cytokines for use in all HALO(R) Assay Kits and HALO(R) Contract Research Services where the response of human blood-forming cells is detected.

ORF Genetics produces a large number of growth factors and cytokines using barley seed as the production host. Their Orfeus(TM) Expression System, comprised of a barley endosperm expression background, gf22 expression cassette, HEKLAgro(TM) cultivation technology, and the production of isogenic lines for seed banking, makes this the most efficient and "green" production of human growth factors and cytokines for R&D medical research, cellular therapy, regenerative medicine, cosmetics and biopharma. ORF Genetics products are free of contaminants for bacterial, viral and prion components; non- pyrogenic; endotoxin-free; and perfectly safe according to FDA guidelines.

Through close collaboration, HemoGenix(R) has tested the growth factors and cytokines produced by ORF Genetics and found them to produce similar, if not superior, potency for growth of human bone marrow, cord blood and peripheral blood cells using its HALO(R) ATP-based, bioluminescence proliferation/cytotoxicity assay platform. The growth factors and cytokines needed to stimulate and detect various blood-forming stem and progenitor cell populations will now be incorporated into the complete line of HALO(R) Assay Kits produced by HemoGenix(R). This is particularly important for the family of HALO(R) quality control and potency assays used to ensure "stem cell quality" and "stem cell potency" for release of stem cell products, particularly umbilical cord blood, prior to transplantation into patients.

HemoGenix(R) will also incorporate ORF Genetics growth factors and cytokines into its HALO(R) Hemotoxici
'/>"/>

SOURCE HemoGenix, Inc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. HemoGenix(R), Inc. Receives Issued Patent for its HALO(R) Technology Platform From the United States Patent and Trademark Office (USPTO).
2. Decision Biomarkers Inc Announces Formation of Scientific Advisory Board
3. Enigma Diagnostics Announces the Opening of a United States Office
4. Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film
5. Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics
6. Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
7. Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing
8. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
9. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
10. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
11. Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinsons Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...s a research industry first, allowing veterinary r... safety study data to be managed in one software a...s, NJ (PRWEB) November 9, 2009 -- Xybion Medical S...ma™ VM, an integrated enterprise software so...and care of veterinary research subjects. Pristima...
(Date:11/8/2009)...9 Complete Genomics, a third-generation human gen...n of a report in the journal Science describing ... analysis of sequence data from three complete hum...enomes sequenced on the proof-of-principle genomic...e to $1,726 for 45x coverage for the samples descr...
(Date:11/6/2009)...rstCall/ -- BioSpecifics Technologies Corp. (Nasda... first-in-class collagenase-based products, today ...ter ended September 30, 2009. ,, "We were extr...DA,s Arthritis Advisory Committee unanimously reco...X(TM) for the treatment of Dupuytren,s disease, an...
(Date:11/6/2009)...wswire/ -- EUCODIS Bioscience, a company,developin...es for the,chemical industry announced today that ...Sidus, the leading biopharmaceutical company in La...S Bioscience exclusive access - for the search,of ...llection of,psychrophilic bacteria strains and oth...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
...therapy reversed hemophilia in mice , , GAITHERSB... today the publication of a new research article, ...nscripts for Production of Therapeutic Proteins I... study describes a novel RNA therapy technique in ...lbumin gene "hijacks" the albumin, causing it to p...
...LE, Ariz., April 6 MedTrust Online, announced tod...l Research Institute (SCRI) at Scottsdale Healthca...e knowledge discovery and collaboration tools at ...ill enable more access to the latest therapies to ...nt for physicians to find and communicate with eac...
... ACI EUROPE, CANSO, EUROCONTROL an...duce the CO2 emitted by aircraft in Europe by over... Geneva, Switzerland (PRWEB) April 6, 2009 ...d a joint action plan designed to reduce the CO2 e...n tonnes a year., , , , ,The plan, launched at the...
Other Biology Technology:VIRxSYS Publishes New Study on RNA Therapy 2MedTrust Online and Scottsdale Clinical Research Institute at Scottsdale Healthcare Announce Collaboration to Provide Cutting Edge Technology to Improve Patient Care 2Aviation partners to cut 500,000 tonnes of CO2 a year 2
(Date:11/9/2009)...gists have had their hands tied because more than ...ble a protein called p53. As a critical anti-cance...g operations within cells. When cells lose p53, tu.... , These tumors might be tough, but they,re no...g Harbor Laboratory (CSHL). The chink in the tumor...
(Date:11/9/2009)...ngs has inspired a 3.2m, three-year research proje...ds of security, energy and the environment. The Un...mpany QinetiQ have just signed a collaborative con...reaking physical sciences research. , Over the ...versity of Exeter and QinetiQ will work together t...
(Date:11/9/2009)... A nutritionist whose research was instrumental in..., Infants and Children (WIC) food subsidy will rec...tstanding achievement in the field of maternal-fet... professor in the Department of Community Health S...es School of Public Health, will receive the award...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2New STR Systems from Promega Comply with Latest DNA Database Standards 14313 1New STR Systems from Promega Comply with Latest DNA Database Standards 14313 2Older Women May Sleep Better Than Men 58638 1Older Women May Sleep Better Than Men 58638 2Heart Pacing Devices Hold Promise for Heart Failure 58636 1Heart Pacing Devices Hold Promise for Heart Failure 58636 2
...N, N.J. Katherine Freed, undergraduate at Stevens...nternational ISPE Undergraduate Poster Contest in ...mpetitor from New Jersey to win this ISPE award. H...d on a project she created with her Senior Design ...gional ISPE Poster Contest was hosted by the Steve...
... release is available in Spanish . , Idiopathic ... with a very severe prognosis; when detected, it i... from it cannot develop with normality pulmonary g...fe. Because of lack of an effective treatment, the...iopathic pulmonary fibrosis affects 13 out of 100,...
...svirus May Play Role in Central Nervous System Dis...esting a herpesvirus may be responsible for some c...from the New York State Department of Public Healt...n the December 2007 issue of the Journal of Clinic... one of the most prevalent in humans. There are t...
Other Biology News:Katherine Freed wins first place at the International ISPE Undergraduate Poster Contest 2Translational research patented first experimental treatment against idiopathic pulmonary fibrosis 2Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3
QIAshredder (50) from QIAGEN
...I 1640 medium with 2 mM L-glutamine and harvested ...antigens in their native forms, cells were fixed i...-well (5 mm) adhesive coated slide, with each well... attachment and to minimize background staining. ...
...PMI 1640 with 2 mM L-glutamine and harvested at th...ens in their native forms, cells were fixed in ace... (5 mm) adhesive coated slide, with each wells sur...chment and to minimize background staining. Each ...
Mouse Anti-Human XPMC2H Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: